nonsmallcell 1
lung 1
cancer 3
breast 1
populationbased 1
study 2
clinicopathologic 1
characteristics 1
survival 1
outcomes 1
women 1
phase 1
ii 1
gemcitabine 1
oxaliplatin 1
combination 1
panitumumab 1
kras 1
wildtype 1
unresectable 1
metastatic 1
biliary 1
tract 1
gallbladder 1
